Find a Physician

Internal Medicine (Board certified since 1977)
Medical Oncology (Board certified since 1979)

hematology/oncology
melanoma

Emory University Hospital

1987

Medical School
Emory University School of Medicine, Atlanta, GA 1974

Internship
Emory University Affiliated Hospitals, Atlanta, GA 1975

Residency
Emory University Affiliated Hospitals, Atlanta, GA 1977

Fellowship
Emory University Affiliated Hospitals, Atlanta, GA 1979

American Association for Cancer Research

American Society for Clinical Oncology

American Society of Biological Therapy



Awards

Alpha Omega Alpha
VA Career Development Program Award
Research Associate



Major or Recent Publications

Granulocyte-macrophage Colony-stimulating Factor: Another Cytokine with Adjuvant Therapeutic Benefit in Melanoma?. Journal of Clinical Oncology,18: 1603-1605.

High-Dose Interferon Alfa-2b Does Not Diminish Antibody Response to GM2 Vaccination in Patients with Resected Melanoma: Results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696. Journal of Clinical Oncology,19: 1430-1436.

Neoadjuvant Interferon Alfa-2b Treatment in a Murine Model for Metastatic Ocular Melanoma: A Preliminary Study. Archives of Opthamology,118 (8): 1085-9.

Paroxetine for the Prevention of Depression Induced by High-Dose Interferon Alfa. New England Journal of Medicine,344: 961-66.